According to Arcadia Biosciences's latest financial reports the company's total assets are โฌ11.24 Million. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | โฌ17.82 M | -33.89% |
2022-12-31 | โฌ26.96 M | -30.47% |
2021-12-31 | โฌ38.77 M | 0.74% |
2020-12-31 | โฌ38.49 M | 32.38% |
2019-12-31 | โฌ29.07 M | 38.47% |
2018-12-31 | โฌ21 M | 52.06% |
2017-12-31 | โฌ13.81 M | -74.32% |
2016-12-31 | โฌ53.78 M | -20.79% |
2015-12-31 | โฌ67.9 M | 231.8% |
2014-12-31 | โฌ20.46 M | 196.18% |
2013-12-31 | โฌ6.9 M | -31.58% |
2012-12-31 | โฌ10.09 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() Marrone Bio Innovations
MBII | N/A | N/A | ๐บ๐ธ USA |
![]() American Vanguard AVD | โฌ0.54 B | 4,762.11% | ๐บ๐ธ USA |
![]() ScottsMiracle-Gro SMG | โฌ3.06 B | 27,126.33% | ๐บ๐ธ USA |
![]() Codexis
CDXS | โฌ0.11 B | 892.20% | ๐บ๐ธ USA |